Sana Biotechnology, Inc.
BalancedSANA·US·🇺🇸 US
45%buys·55%sales
635 transactions$180.7MTotal buys·49 buys
$31.5MTotal sells·61 sells
4343 insiders
Last: Dec 15, 2025
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 6, 26 | Bishop Hans Edgar | Grant | - | |
| Dec 15, 25 | Wyrick Susan D. | Other | $5K | |
| Dec 13, 25 | Wyrick Susan D. | Exercise | - | |
| Dec 13, 25 | Wyrick Susan D. | Exercise | - | |
| Dec 4, 25 | Wyrick Susan D. | Other | $11K | |
| Dec 3, 25 | Wyrick Susan D. | Exercise | - | |
| Dec 3, 25 | Wyrick Susan D. | Exercise | - | |
| Oct 6, 25 | Bishop Hans Edgar | Grant | - | |
| Jul 7, 25 | Bishop Hans Edgar | Grant | - | |
| Jun 5, 25 | Yang Patrick Y | Grant | - |
Sana Biotechnology, Inc. (SANA) has recorded 635 insider transactions from 43 insiders. Total insider buying volume stands at $180.7M, while total selling volume is $31.5M. Insider activity shows a balanced mix of buying and selling.
Sana Biotechnology, Inc. (SANA) has recorded 635 insider operations, including 49 open-market purchases ($180.7M), 61 sales ($31.5M) and 525 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is balanced.
Sana Biotechnology, Inc. shows moderate insider activity with 6 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are Harr Steve (CEO), Hardy Nathan (CFO) & Hordo Christian (C SUITE), with respectively 57, 5, 26 transactions.
Across all 637 recorded transactions, the breakdown by type is: exercise (340, 53%), grant (121, 19%), sales (61, 10%), other (55, 9%), buys (49, 8%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Sana Biotechnology, Inc. has recorded 635 insider operations in total, including 49 open-market purchases ($180.7M), 61 sales ($31.5M) and 525 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on December 15, 2025.
Insiders at Sana Biotechnology, Inc. show balanced activity with 45% purchases and 55% sales. Total buy volume is $180.7M versus $31.5M in sales.
InsiderLens tracks 43 insiders at Sana Biotechnology, Inc. (SANA). Harr Steve (CEO, 57 tx), Hardy Nathan (CFO, 5 tx), Hordo Christian (C SUITE, 26 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for SANA is neutral, based on a 45% buy ratio across 110 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Sana Biotechnology, Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.